Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods
- PMID: 10178496
Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods
Abstract
We conducted a study of the sensitivity, specificity, positive predictive value, and cost of two methods of identifying diagnosed diabetes mellitus or heart disease among members of a health maintenance organization (HMO). Among 3186 adult HMO members who were attending one primary care clinic, 2326 were reached for a telephone survey (efficiency = 0.73). Among these members, 1991 answered standardized questions to ascertain whether they had diabetes or heart disease (corrected response rate = 0.85). Linkage was then made to computerized diagnostic databases. By means of both a database method and a survey method, the 1976 members with complete data for analysis were classified as having or not having diabetes or heart disease. When results with the two methods disagreed, charts were reviewed to confirm the presence or absence of diabetes or heart disease. Diabetes was identified among 4.7% of adult members, and heart disease was identified among 3.7%. Identification of diabetes differed between the database method and the survey method (sensitivity 0.91 vs 0.98, specificity 0.99 vs 0.99, positive predictive value 0.94 vs 0.83). Identification of heart attach history was similar for the database method and the survey method (sensitivity 0.89 vs 0.95, specificity 0.99 vs 0.99, positive predictive value 0.79 vs 0.81). The cost of obtaining data was $13.50 per member for the survey method and $0.30 per member for the database method. Database methods or survey methods of identifying selected chronic diseases among HMO members may be acceptable for various purposes, but database identification methods appear to be less expensive and provide information on a higher proportion of HMO members than do survey methods. Accurate identification of chronic diseases among patients supports clinic-level measures for clinical improvement, research, and accountability.
Similar articles
-
Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.Clin Ther. 2007 Aug;29(8):1761-70. doi: 10.1016/j.clinthera.2007.08.022. Clin Ther. 2007. PMID: 17919557
-
Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data.Ann Epidemiol. 2004 Aug;14(7):507-16. doi: 10.1016/j.annepidem.2003.09.016. Ann Epidemiol. 2004. PMID: 15301787 Review.
-
Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data.Am J Manag Care. 2004 Apr;10(4):257-62. Am J Manag Care. 2004. PMID: 15124502
-
Does professional advice influence aspirin use to prevent heart disease in an HMO population?Eff Clin Pract. 1998 Aug-Sep;1(1):26-32. Eff Clin Pract. 1998. PMID: 10345257
-
Chronic disease, functional health status, and demographics: a multi-dimensional approach to risk adjustment.Health Serv Res. 1996 Aug;31(3):283-307. Health Serv Res. 1996. PMID: 8698586 Free PMC article. Clinical Trial.
Cited by
-
Recent Trends in Diabetes-Associated Hospitalizations in the United States.J Clin Med. 2022 Nov 9;11(22):6636. doi: 10.3390/jcm11226636. J Clin Med. 2022. PMID: 36431114 Free PMC article.
-
Revisiting the Obesity Paradox in Health Care Expenditures Among Adults With Diabetes.Clin Diabetes. 2022 Spring;40(2):185-195. doi: 10.2337/cd20-0122. Epub 2022 Apr 15. Clin Diabetes. 2022. PMID: 35669295 Free PMC article.
-
Risk and Risk Factors for Postpartum Type 2 Diabetes Mellitus in Women with Gestational Diabetes: A Korean Nationwide Cohort Study.Endocrinol Metab (Seoul). 2022 Feb;37(1):112-123. doi: 10.3803/EnM.2021.1276. Epub 2022 Feb 28. Endocrinol Metab (Seoul). 2022. PMID: 35255605 Free PMC article.
-
Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis.BMC Rheumatol. 2020 Sep 2;4:39. doi: 10.1186/s41927-020-00138-3. eCollection 2020. BMC Rheumatol. 2020. PMID: 32905192 Free PMC article.
-
Identifying Common Predictors of Multiple Adverse Outcomes Among Elderly Adults With Type-2 Diabetes.Med Care. 2019 Sep;57(9):702-709. doi: 10.1097/MLR.0000000000001159. Med Care. 2019. PMID: 31356411 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical